Activated T cell radioimmunotherapy is improved by immunomodulation through enhanced radiolabeled antibody retention in lymph node in an experimental multiple sclerosis model

Authors
Category Primary study
Conference26th International Symposium on Radiopharmaceutical Sciences, iSRS 2025
Year 2025
This article has no abstract
Epistemonikos ID: 9de27425ddacb1ffe307f0400687568574a1cce3
First added on: Jul 04, 2026